D-0018-2015 Class III Terminated

Recalled by Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

FDA drug recall D-0018-2015 was initiated by Valeant Pharmaceuticals North America LLC on May 21, 2014 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset The recall status is terminated (terminated Aug 4, 2015). Affected quantity: 205,853 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 22, 2014
Initiation Date
May 21, 2014
Termination Date
Aug 4, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
205,853 bottles

Product description

Vaseretic (enalapril maleate/hydrochlorothiazide) 10/25 mg Tablets, NDC 0187-0146-01, 100 ct. bottles manufactured at Valeant Pharmaceuticals International, Inc., Steinbach, MD R5G 1Z7 Canada

Reason for recall

Labeling: Incorrect or Missing Package Insert: Product is packaged with the incorrect version of the package outset

Distribution pattern

Nationwide

Code information

VASERETIC 10-25MG TAB 100CT Lot # 12J022P exp. 9/30/2014 VASERETIC 10-25MG TAB 100CT Lot # 13G047P exp. 07/31/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0018-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0018-2015. Report a data issue: hello@regdatalab.com.